Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T22:43:21.078Z.
Calculation as of: 2026-10-06T22:43:21.078Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ffcae252daa6a300827ff3558097e5e2d7e407771ad67afba685997be4cf909d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-16.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.59B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.54B
EV/EBIT Ratio
N/A
TTM Avg
449.30x
3Y Avg
449.30x
5Y Avg
449.30x
Market Cap
$1.61B
EV/EBIT Ratio
25.79x
TTM Avg
110.32x
3Y Avg
127.60x
5Y Avg
102.82x
Market Cap
$1.62B
EV/EBIT Ratio
N/A
TTM Avg
33.08x
3Y Avg
33.08x
5Y Avg
33.08x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | $1.57B | N/A | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | N/A | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.60B | N/A | 1.97x | 2.00x | 2.00x |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | N/A | 449.30x | 449.30x | 449.30x |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | N/A | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 7.61x | 117.97x | 74.38x | 44.05x |
| Septerna Inc (SEPN)vs › | $1.61B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 25.79x | 110.32x | 127.60x | 102.82x |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | N/A | 33.08x | 33.08x | 33.08x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 10.63x | 32.14x | 262.80x | 252.98x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-03-16 | 70.23x |
| 2026-03-13 | 68.57x |
| 2026-03-12 | 75.66x |
| 2026-03-11 | 78.81x |
| 2026-03-10 | 79.69x |
| 2026-03-09 | 79.60x |
| 2026-03-06 | 73.51x |
| 2026-03-05 | 71.72x |
| 2026-03-04 | 71.22x |
| 2026-03-03 | 69.84x |
| 2026-03-02 | 76.11x |
| 2026-02-27 | 75.51x |
| 2026-02-26 | 73.66x |
| 2026-02-25 | 73.55x |
| 2026-02-24 | 73.55x |
| 2026-02-23 | 75.12x |
| 2026-02-20 | 70.94x |
| 2026-02-19 | 71.11x |
| 2026-02-18 | 63.81x |
| 2026-02-17 | 64.04x |
| 2026-02-13 | 65.81x |
| 2026-02-12 | 65.77x |
| 2026-02-11 | 66.48x |
| 2026-02-10 | 66.95x |
| 2026-02-09 | 65.98x |
| 2026-02-06 | 66.87x |
| 2026-02-05 | 62.73x |
| 2026-02-04 | 66.01x |
| 2026-02-03 | 69.86x |
| 2026-02-02 | 63.35x |
| 2026-01-30 | 62.43x |
| 2026-01-29 | 64.00x |
| 2026-01-28 | 60.40x |
| 2026-01-27 | 60.64x |
| 2026-01-26 | 60.08x |
| 2026-01-23 | 60.53x |
| 2026-01-22 | 61.80x |
| 2026-01-21 | 60.62x |
| 2026-01-20 | 58.94x |
| 2026-01-16 | 58.89x |
| 2026-01-15 | 60.14x |
| 2026-01-14 | 63.79x |
| 2026-01-13 | 62.95x |
| 2026-01-12 | 60.45x |
| 2026-01-09 | 67.84x |
| 2026-01-08 | 69.63x |
| 2026-01-07 | 72.84x |
| 2026-01-06 | 72.95x |
| 2026-01-05 | 67.19x |
| 2026-01-02 | 63.63x |
| 2025-12-31 | 65.45x |
| 2025-12-30 | 65.62x |
| 2025-12-29 | 66.39x |
| 2025-12-26 | 65.83x |
| 2025-12-24 | 66.37x |
| 2025-12-23 | 65.70x |
| 2025-12-22 | 69.28x |
| 2025-12-19 | 65.92x |
| 2025-12-18 | 65.85x |
| 2025-12-17 | 67.86x |
| 2025-12-16 | 69.48x |
| 2025-12-15 | 68.12x |
| 2025-12-12 | 66.85x |
| 2025-12-11 | 68.35x |
| 2025-12-10 | 70.64x |
| 2025-12-09 | 62.71x |
| 2025-12-08 | 68.16x |
| 2025-12-05 | 63.57x |
| 2025-12-04 | 63.96x |
| 2025-12-03 | 63.76x |
| 2025-12-02 | 61.29x |
| 2025-12-01 | 61.89x |
| 2025-11-28 | 63.66x |
| 2025-11-26 | 64.30x |
| 2025-11-25 | 61.31x |
| 2025-11-24 | 62.43x |
| 2025-11-21 | 60.27x |
| 2025-11-20 | 57.23x |
| 2025-11-19 | 58.42x |
| 2025-11-18 | 59.37x |
| 2025-11-17 | 55.12x |
| 2025-11-14 | 54.17x |
| 2025-11-13 | 53.23x |
| 2025-11-12 | 51.20x |
| 2025-11-11 | 51.16x |
| 2025-11-10 | 45.25x |
| 2025-11-07 | 46.31x |
| 2025-11-06 | 45.47x |
| 2025-11-05 | 46.22x |
| 2025-11-04 | 34.24x |
| 2025-11-03 | 35.35x |
| 2025-10-31 | 41.05x |
| 2025-10-30 | 43.46x |
| 2025-10-29 | 43.04x |
| 2025-10-28 | 43.36x |
| 2025-10-27 | 45.34x |
| 2025-10-24 | 44.30x |
| 2025-10-23 | 43.44x |
| 2025-10-22 | 44.65x |
| 2025-10-21 | 47.77x |
| 2025-10-20 | 47.73x |
| 2025-10-17 | 46.11x |
| 2025-10-16 | 47.04x |
| 2025-10-15 | 49.11x |
| 2025-10-14 | 48.15x |
| 2025-10-13 | 41.49x |
| 2025-10-10 | 41.27x |
| 2025-10-09 | 40.85x |
| 2025-10-08 | 41.72x |
| 2025-10-07 | 37.10x |
| 2025-10-06 | 36.37x |
| 2025-10-03 | 34.56x |
| 2025-10-02 | 33.49x |
| 2025-10-01 | 31.71x |
| 2025-09-30 | 31.58x |
| 2025-09-29 | 33.36x |
| 2025-09-26 | 32.51x |
| 2025-09-25 | 30.78x |
| 2025-09-24 | 30.64x |
| 2025-09-23 | 30.32x |
| 2025-09-22 | 30.64x |
| 2025-09-19 | 30.71x |
| 2025-09-18 | 31.58x |
| 2025-09-17 | 30.48x |
| 2025-09-16 | 31.09x |
| 2025-09-15 | 31.43x |
| 2025-09-12 | 31.52x |
| 2025-09-11 | 32.13x |
| 2025-09-10 | 30.36x |
| 2025-09-09 | 29.51x |
| 2025-09-08 | 29.39x |
| 2025-09-05 | 27.49x |
| 2025-09-04 | 25.97x |
| 2025-09-03 | 26.18x |
| 2025-09-02 | 25.92x |
| 2025-08-29 | 26.16x |
| 2025-08-28 | 26.18x |
| 2025-08-27 | 25.50x |
| 2025-08-26 | 25.60x |
| 2025-08-25 | 24.87x |
| 2025-08-22 | 25.87x |
| 2025-08-21 | 26.05x |
| 2025-08-20 | 25.52x |
| 2025-08-19 | 24.32x |
| 2025-08-18 | 24.35x |
| 2025-08-15 | 23.92x |
| 2025-08-14 | 22.41x |
| 2025-08-13 | 22.03x |
| 2025-08-12 | 13.89x |
| 2025-08-11 | 13.32x |
| 2025-08-08 | 13.22x |
| 2025-08-07 | 13.46x |
| 2025-08-06 | 13.33x |
| 2025-08-05 | 13.01x |
| 2025-08-04 | 13.28x |
| 2025-08-01 | 12.93x |
| 2025-07-31 | 12.83x |
| 2025-07-30 | 12.87x |
| 2025-07-29 | 12.29x |
| 2025-07-28 | 12.77x |
| 2025-07-25 | 13.22x |
| 2025-07-24 | 13.86x |
| 2025-07-23 | 15.04x |
| 2025-07-22 | 13.95x |
| 2025-07-21 | 12.00x |
| 2025-07-18 | 13.41x |
| 2025-07-17 | 12.06x |
| 2025-07-16 | 11.36x |
| 2025-07-15 | 11.13x |
| 2025-07-14 | 11.61x |
| 2025-07-11 | 11.30x |
| 2025-07-10 | 11.58x |
| 2025-07-09 | 11.55x |
| 2025-07-08 | 11.53x |
| 2025-07-07 | 11.03x |
| 2025-07-03 | 10.71x |
| 2025-07-02 | 10.82x |
| 2025-07-01 | 10.97x |
| 2025-06-30 | 10.50x |
| 2025-06-27 | 10.94x |
| 2025-06-26 | 11.27x |
| 2025-06-25 | 11.22x |
| 2025-06-24 | 10.75x |
| 2025-06-23 | 10.88x |
| 2025-06-20 | 10.86x |
| 2025-06-18 | 10.85x |
| 2025-06-17 | 10.99x |
| 2025-06-16 | 11.05x |
| 2025-06-13 | 10.78x |
| 2025-06-12 | 11.23x |
| 2025-06-11 | 10.74x |
| 2025-06-10 | 10.52x |
| 2025-06-09 | 10.16x |
| 2025-06-06 | 10.18x |
| 2025-06-05 | 9.77x |
| 2025-06-04 | 9.87x |
| 2025-06-03 | 9.81x |
| 2025-06-02 | 8.27x |
| 2025-05-30 | 7.69x |
| 2025-05-29 | 7.99x |
| 2025-05-28 | 7.52x |
| 2025-05-27 | 7.13x |
| 2025-05-23 | 7.41x |
| 2025-05-22 | 7.63x |
| 2025-05-21 | 7.60x |
| 2025-05-20 | 8.49x |
| 2025-05-19 | 8.14x |
| 2025-05-16 | 8.03x |
| 2025-05-15 | 7.83x |
| 2025-05-14 | 6.84x |
